President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Joslin & USDA Program Recognized by ADA Disparities Forum

Joslin's

Sarah Imershein, MPH,
and Rich Jackson, MD

Wednesday, February 24, 2010

Joslin's "On the Road" outreach program, developed in collaboration with USDA, received the “Promising Practice” award at the American Diabetes Association’s 3rd Annual Disparities Partnership Forum for its ability to reach and effectively impact low-income and underserved populations with an easy-to-deliver program.

The program has demonstrated impressive blood pressure outcomes in both the On the Road to Living Well module and the new physical activity module: Keep Moving -- Keep Healthy (KMKH) during this last program year. 

Participants in KMKH reported significant increase (p<0.004) in days of physical activity per week, and participants who increased activity showed a 6.6 mmHg greater drop in systolic blood pressure than those who did not increase activity (p<0.027). 

The program has always welcomed caregivers and concerned individuals to attend, but in 2009 special emphasis was placed on recruiting and retaining these individuals. 

Data suggest that "On the Road" has a significant impact on these high-risk, undiagnosed participants and can significantly lower key biomarkers.  These promising outcomes suggest the program may be effective in preventing or delaying the onset of type 2 diabetes and reduction of other risk factors such as those for metabolic syndrome.

To find out more about the "On the Road" program, please contact Rich Jackson, MD, or Sarah Imershein, MPH, of Joslin’s Healthcare Services team.

Joslin's

Page last updated: November 23, 2014